The Definitive Link Between Muscular Strength And Longevity For Women
Posted on
In a new JAMA study “Muscular Strength and Mortality in Women Aged 63 to 99 Years”, by LaMonte et al. (2026), the researchers identified several key differences and improvements over previous research concerning the link between muscular strength and longevity.
In this cohort study of 5472 women aged 63 to 99 years, common strength tests were associated with significantly lower mortality risk after controlling for sociodemographic and clinical characteristics, accelerometer measured physical activity and sedentary behavior, and timed walk.
Muscle strength was associated with lower mortality even in women not meeting guideline-recommended activity levels.
How the 2026 Study Differs from Previous Research
The primary distinction of this new study is the precision and scope of its control variables. While previous studies often relied on self-reported data, this study used objective measurements to isolate the specific impact of muscle strength on mortality.
Objective Movement Measurement: Unlike previous studies that used self-reported activity levels, this research utilized accelerometer-measured physical activity and sedentary time. This allowed researchers to confirm that the benefits of strength remained significant regardless of how much a person actually moved during the day.
Controlling for “Fitness” Levels: The study specifically accounted for walking speed as a proxy for cardiorespiratory fitness. This helped determine if the lower mortality risk was due to general fitness or specifically to muscular strength.
Inflammation Analysis: The researchers controlled for C-reactive protein (CRP), a biological marker of systemic inflammation. This addressed whether strength protects longevity by reducing inflammation or through other biological pathways.
Focus on Older Women: While many studies look at broad populations, this cohort focused exclusively on ambulatory women aged 63 to 99, providing more specific data for this demographic.
Problems with Previous Studies
The LaMonte study highlights several limitations in earlier research that it sought to rectify:
Self-Report Bias: Previous studies heavily relied on participants self-reporting their aerobic activity and sedentary time. This is often inaccurate because self-reports do not capture all daily movements and frequently underestimate sedentary behavior, especially in older adults.
Confounding Variables: Many earlier studies failed to separate the effects of muscle strength from cardiorespiratory fitness. Because fit people tend to be both stronger and have better heart health, it was previously difficult to prove that strength itself was the predictor of longevity.
Biological Oversight: Most prior research did not account for aging-related inflammation, which is known to cause mitochondrial dysfunction and impair muscle function. Without controlling for this, it was unclear if strength was merely a “symptom” of low inflammation rather than a driver of longevity.
Grip Strength As An Independent Longevity Predictor
The most notable finding of the 2026 LaMonte study is that muscular strength is an independent predictor of longevity, maintaining a significant inverse association with mortality even after controlling for factors that previously clouded this relationship.
While previous research often relied on self-reported activity, this study utilized accelerometer-measured physical activity and sedentary time, confirming that the protective benefits of strength exist regardless of how much a person moves or sits during the day.
Risk Reduction: Women in the highest quartile of grip strength (>24 kg) had a 33% lower risk of death (HR 0.67) compared to those in the lowest quartile (<14 kg), even after rigorous adjustment for sociodemographic, lifestyle, and clinical factors.
Guideline Independence: Perhaps most significantly, the study found that high muscle strength was associated with lower mortality even in women who did not meet the national guidelines for recommended weekly aerobic activity.
Robust Across Biological Markers: The link remained strong even when the researchers accounted for walking speed (a proxy for cardiovascular fitness) and C-reactive protein (a marker of systemic inflammation), suggesting that strength provides a unique survival benefit that is not just a byproduct of being “fit” or having low inflammation.
Consistency Across Demographics: The protective effect of strength did not differ significantly based on age, race, ethnicity, or BMI, indicating it is a universal marker of resilience in older women.
Final Word
Perhaps the most practically useful result: muscular strength was associated with lower mortality even in women who weren’t meeting aerobic activity guidelines. This matters because some older women simply can’t sustain regular aerobic exercise but might still be able to do resistance training or maintain baseline strength – and this study suggests that still confers a real survival benefit.
The study isn’t without its own limitations – it’s women only, it estimated rather than directly measured lean body mass, and walking speed is still just a proxy for fitness rather than a direct VO2 max measurement. But it’s a considerably more rigorous test of the strength–longevity relationship than what came before.
